Skip to main content

Vanadis Core T21/T18/T13 Reagent Cartridge

Vanadis Core® qualitative assay for screening the risk of trisomy 21, 18, and/or 13.

Products may not be licensed in accordance with the laws in all countries, such as the United States. Please check with your local representative for availability.

Feature Specification
Application Noninvasive Prenatal Testing (NIPT)

Vanadis Core® qualitative assay for screening the risk of trisomy 21, 18, and/or 13.

Products may not be licensed in accordance with the laws in all countries, such as the United States. Please check with your local representative for availability.

Product Variant
Unit Size: 84 samples
Part #:
3222-001B
Request More Information

Overview

Qualitative assay intended for an in vitro diagnostic use to act as an aid in screening for the risk of trisomy 21, 18, and/or 13 in fetus using cell-free DNA from pregnant women of at least 10 weeks of gestation.

Specifications

Application
Noninvasive Prenatal Testing (NIPT)
Brand
Vanadis Core®
Disorders
Common Trisomies
Instrument Compatibility
Vanadis NIPT System
Sample Type
Serum
Technology
Rolling Circle Amplification (RCA)
Unit Size
84 samples

Resources

Are you looking for resources, click on the resource type to explore further.

Scroll Icon